These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16376037)

  • 1. A mathematical model for interpreting in vitro rhGH release from laminar implants.
    Santoveña A; García JT; Oliva A; Llabrés M; Fariña JB
    Int J Pharm; 2006 Feb; 309(1-2):38-43. PubMed ID: 16376037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
    Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
    J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK; Chung HJ; Park TG
    J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drug type on the degradation rate of PLGA matrices.
    Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
    Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
    Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable laminar implants for sustained release of recombinant human growth hormone.
    García J; Dorta MJ; Munguía O; Llabrés M; Fariña JB
    Biomaterials; 2002 Dec; 23(24):4759-64. PubMed ID: 12361614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
    Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
    Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer.
    Santoveña A; Fariña JB; Llabrés M; Zhu Y; Dannies P
    Int J Pharm; 2010 Mar; 388(1-2):175-80. PubMed ID: 20060456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S; Tros de Ilarduya C
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated temperature accelerated release testing of PLGA microspheres.
    Zolnik BS; Leary PE; Burgess DJ
    J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.
    Wei G; Lu LF; Lu WY
    Int J Pharm; 2007 Jun; 338(1-2):125-32. PubMed ID: 17336005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A linear mixed-effects statistical model for in-vivo evaluation of recombinant human growth hormone implants in hypophysectomized rats.
    Santoveña A; García JT; Fariña JB; Llabrés M
    J Pharm Pharmacol; 2007 Sep; 59(9):1313-7. PubMed ID: 17883903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.